News on Celgene Corporation from BioPortfolio.com http://www.BioPortfolio.com Consolidated Celgene Corporation news from BioPortfolio.com Wed, 10 Feb 2010 09:30:24 GMT en Illuminating Uveitis; Lux Seeks Luveniq Approval in U.S., Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020372&HITNO=0&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020372&THISHREF=http://c.moreover.com/click/here.pl%3fz2526721573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020372&HITNO=0&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020372&THISHREF=http://c.moreover.com/click/here.pl%3fz2526721573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: Teva, Novartis, Celgene Settle Patent Lawsuit Over Generic Focalinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009745&HITNO=1&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009745&THISHREF=http://c.moreover.com/click/here.pl%3fz2522072774%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009745&HITNO=1&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009745&THISHREF=http://c.moreover.com/click/here.pl%3fz2522072774%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFDA News: Beacon Equity Issues BioPharmaceutical Stock Alert for Array BioPharma Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006197&HITNO=2&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006197&THISHREF=http://c.moreover.com/click/here.pl%3fz2520624448%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006197&HITNO=2&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006197&THISHREF=http://c.moreover.com/click/here.pl%3fz2520624448%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Beacon Equity Issues BioPharmaceutical Stock Alert for Array BioPharma Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004736&HITNO=3&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004736&THISHREF=http://c.moreover.com/click/here.pl%3fz2520090554%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004736&HITNO=3&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004736&THISHREF=http://c.moreover.com/click/here.pl%3fz2520090554%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDMN Newswire: Beacon Equity Issues BioPharmaceutical Stock Alert for Array BioP...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004689&HITNO=4&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004689&THISHREF=http://c.moreover.com/click/here.pl%3fz2520078174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004689&HITNO=4&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004689&THISHREF=http://c.moreover.com/click/here.pl%3fz2520078174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Beacon Equity Issues BioPharmaceutical Stock Alert for Arrayhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004652&HITNO=5&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004652&THISHREF=http://c.moreover.com/click/here.pl%3fz2520062456%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004652&HITNO=5&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004652&THISHREF=http://c.moreover.com/click/here.pl%3fz2520062456%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobeNewswire via MSN Money: Beacon Equity Issues BioPharmaceutical Stock Alert for Array BioPharma Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004614&HITNO=6&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004614&THISHREF=http://c.moreover.com/click/here.pl%3fz2520055403%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004614&HITNO=6&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004614&THISHREF=http://c.moreover.com/click/here.pl%3fz2520055403%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInterest!ALERT: Beacon Equity Issues BioPharmaceutical Stock Alert for Array BioPharma Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004534&HITNO=7&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004534&THISHREF=http://c.moreover.com/click/here.pl%3fz2520005161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004534&HITNO=7&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004534&THISHREF=http://c.moreover.com/click/here.pl%3fz2520005161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Celgene, Novartis Settle With Teva In Focalin IP Suitshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000562&HITNO=8&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000562&THISHREF=http://c.moreover.com/click/here.pl%3fz2518088592%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000562&HITNO=8&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000562&THISHREF=http://c.moreover.com/click/here.pl%3fz2518088592%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLaw360: Research and Markets: Drive the Roadmap for Success in Oncology as Global Oncology Market is Projected to Outghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996883&HITNO=9&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996883&THISHREF=http://c.moreover.com/click/here.pl%3fz2516501196%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996883&HITNO=9&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996883&THISHREF=http://c.moreover.com/click/here.pl%3fz2516501196%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Deal watch: Celgene acquires Gloucester Pharmaceuticals, gaining approved HDAC inhibitorhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990036&HITNO=10&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990036&THISHREF=http://c.moreover.com/click/here.pl%3fz2513073073%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990036&HITNO=10&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990036&THISHREF=http://c.moreover.com/click/here.pl%3fz2513073073%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNature Reviews Drug Discovery: Pepscan Therapeutics Strengthens Management Teamhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994157&HITNO=11&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994157&THISHREF=http://c.moreover.com/click/here.pl%3fz2514896664%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994157&HITNO=11&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994157&THISHREF=http://c.moreover.com/click/here.pl%3fz2514896664%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Ligand to Report Fourth Quarter Results on February 9thhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993664&HITNO=12&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993664&THISHREF=http://c.moreover.com/click/here.pl%3fz2514704074%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993664&HITNO=12&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993664&THISHREF=http://c.moreover.com/click/here.pl%3fz2514704074%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Epigenetics Offers Strategies for New Drugshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993482&HITNO=13&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993482&THISHREF=http://c.moreover.com/click/here.pl%3fz2514612979%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993482&HITNO=13&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993482&THISHREF=http://c.moreover.com/click/here.pl%3fz2514612979%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Ligand to Report Fourth Quarter Results on February 9thhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3992729&HITNO=14&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3992729&THISHREF=http://c.moreover.com/click/here.pl%3fz2514305230%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3992729&HITNO=14&MSIZE=197&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Celgene%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3992729&THISHREF=http://c.moreover.com/click/here.pl%3fz2514305230%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: